First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

Researchers from St. Jude Children's Research Hospital and the Chinese Children's Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for acute lymphoblastic leukemia (ALL) driven by the Philadelphia chromosome.